TY - JOUR
T1 - Research planning for the future of psychiatric diagnosis
AU - Regier, D. A.
AU - Kuhl, E. A.
AU - Narrow, W. E.
AU - Kupfer, D. J.
N1 - Funding Information:
At the close of this initial phase of DSM-5 development, APIRE received a $1.1 million grant from the National Institutes of Health (NIH) to convene a series of international planning conferences. These meetings were designed with three primary goals in mind: to stimulate the empirical research base for future changes in diagnostic classification; to promote international collaboration for cross-talk between DSM-5 and the forthcoming 11th edition of the International Classification of Diseases (ICD-11); and to begin building a consensus about revised criteria, in an effort to maximize clinical and research validity of DSM-5 diagnoses. The conference series, which was jointly sponsored by NIMH, the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, and the World Health Organization (WHO), organized 13 diagnosis-specific international meetings over the span of 5 years, from 2003–2008. As a result, more than 190 scholarly articles and 13 white paper monographs [4,9–11,14,16,20–22,27,31,32,35] have been published as resource documents for the DSM-5 Task Force and Work Group members. These publications have become integral components to the literature reviews conducted by the DSM-5 Work Groups to assess the current state of the criteria and determine which revisions are warranted. Since one of the aims of the conference series was to provide specific recommendations for how DSM-5 might address gaps in the literature, each monograph provides summary content theorizing how DSM-5 might begin to answer the numerous questions raised throughout the meetings. This has made the monograph series particularly valuable to the revision process.
PY - 2012/10
Y1 - 2012/10
N2 - More than 10 years prior to the anticipated 2013 publication of DSM-5, processes were set in motion to assess the research and clinical issues that would best inform future diagnostic classification of mental disorders. These efforts intended to identify the clinical and research needs within various populations, examine the current state of the science to determine the empirical evidence for improving criteria within and across disorders, and stimulate research in areas that could potentially provide evidence for change. In the second phase of the revision process, the American Psychiatric Institute for Research and Education (APIRE) recently completed the 5-year international series of 13 diagnostic conferences convened by APA/APIRE in collaboration with the World Health Organization and the National Institutes of Health (NIH), under a cooperative grant funded by the NIH. From these conferences, the DSM-5 Task Force and Work Groups have developed plans for potential revisions for DSM-5, including the incorporation of dimensional approaches within and across diagnostic groups to clarify heterogeneity, improve diagnostic validity, and enhance clinical case conceptualization. Use of dimensions for measurement-based care has been shown to be feasible in psychiatric and primary care settings and may inform monitoring of disorder threshold, severity, and treatment outcomes. The integration of dimensions with diagnostic categories represents an exciting and potentially transformative approach for DSM-5 to simultaneously address DSM-IV's clinical short-comings and create novel pathways for research in neurobiology, genetics, and psychiatric epidemiology.
AB - More than 10 years prior to the anticipated 2013 publication of DSM-5, processes were set in motion to assess the research and clinical issues that would best inform future diagnostic classification of mental disorders. These efforts intended to identify the clinical and research needs within various populations, examine the current state of the science to determine the empirical evidence for improving criteria within and across disorders, and stimulate research in areas that could potentially provide evidence for change. In the second phase of the revision process, the American Psychiatric Institute for Research and Education (APIRE) recently completed the 5-year international series of 13 diagnostic conferences convened by APA/APIRE in collaboration with the World Health Organization and the National Institutes of Health (NIH), under a cooperative grant funded by the NIH. From these conferences, the DSM-5 Task Force and Work Groups have developed plans for potential revisions for DSM-5, including the incorporation of dimensional approaches within and across diagnostic groups to clarify heterogeneity, improve diagnostic validity, and enhance clinical case conceptualization. Use of dimensions for measurement-based care has been shown to be feasible in psychiatric and primary care settings and may inform monitoring of disorder threshold, severity, and treatment outcomes. The integration of dimensions with diagnostic categories represents an exciting and potentially transformative approach for DSM-5 to simultaneously address DSM-IV's clinical short-comings and create novel pathways for research in neurobiology, genetics, and psychiatric epidemiology.
KW - Classification of psychiatric disorders
KW - DSM-5
KW - ICD-11
KW - Psychiatric nosology
UR - http://www.scopus.com/inward/record.url?scp=84866440107&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866440107&partnerID=8YFLogxK
U2 - 10.1016/j.eurpsy.2009.11.013
DO - 10.1016/j.eurpsy.2009.11.013
M3 - Article
C2 - 21676595
AN - SCOPUS:84866440107
SN - 0924-9338
VL - 27
SP - 553
EP - 556
JO - Psychiatrie et Psychobiologie
JF - Psychiatrie et Psychobiologie
IS - 7
ER -